PRESS RELEASES

May, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW RESEARCH BULLETIN BOARD: THE IMPACT OF BIOSIMILAR DRUGS ON MARKET ACCESS

Health Strategies Group has announced the launch of a new turnkey research focused on the impact of biosimilars on market access.

April, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW SUITE OF SERVICES FOR MARKET ACCESS BRAND MARKETERS

Health Strategies Group has announced the launch of a new suite of services for market access brand marketers that features three new services that organizes content around a client’s business questions – specific to their therapeutic market across multiple customer segments.

April, 2016

HEALTH STRATEGIES GROUP LAUNCHES ONCOLOGY RESOURCE HUB

The multimedia platform provides a wide range of white papers, articles, insights and webinars covering 10+ years of oncology specific market access market research online for downloading – Free!

March, 2016

SEVEN COMPANIES HAVE THE BEST RELATIONSHIPS WITH PHARMACY DECISION MAKERS IN HOSPITALS AND HEALTH SYSTEMS

AbbVie, GSK, Johnson & Johnson HCS, Lilly, Merck, Novo Nordisk, and Pfizer earn high praise from pharmacy leaders

March, 2016

SEVEN COMPANIES ACHIEVE BEST-IN-CLASS STATUS AMONG MANAGED CARE DECISION MAKERS

GlaxoSmithKline, J&J, Lilly, Merck, Novartis, Novo Nordisk, and Pfizer have implemented successful approaches with health plans and pharmacy benefit managers

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.